Public Health Focused and Research-Based

The services we offer are based on the latest and leading research. This enables us to ensure that you receive the best quality advice, wherever you travel. Our research areas include travel medicine, various communicable diseases such as HIV or tuberculosis, and emerging pathogens such as SARS-CoV2. We are also the coordinating center for the Swiss-wide Corona antibody study Corona Immunitas.

Further publications and research projects can be found on the website of our parent institute, the Epidemiology, Biostatistics and Prevention Institute.

Would you like to participate in one of our studies? These studies are currently enrolling participants.


Bildschirmfoto 2022-11-16 um 13.35.33


ITIT = Illness Tracking in Travellers


Travel medicine needs your story!


Take part in a citizen science project to show trends in traveller infections and help to identify outbreaks as they happen.


Find more information here.


Pycnovid Study

Study participants wanted for "Long COVID" (Post Covid-19 Syndrome) study.

A study is planned at the Institute of Epidemiology, Biostatistics and Prevention at the University of Zurich under the direction of Prof Dr. Jan Fehr (sponsor) to investigate the natural remedy Pycnogenol® in people affected with Long COVID. The aim is to investigate whether Pycnogenol® leads to an improvement in the state of health and an improvement in the symptoms associated with Long COVID compared to placebo.

For more information, please see the flyer. The study team will be happy to answer any further questions you may have.


E-mail: pycnovid@ebpi.uzh.ch


Bildschirmfoto 2023-06-08 um 11.26.25







Do you have any questions or would you like to book an appointment?